Cite
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF
MLA
Senthil, Selvaraj, et al. “Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.” Circulation, vol. 146, no. 11, Sept. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21f8b9870ff2acbe19e09e991ae63ed8&authtype=sso&custid=ns315887.
APA
Senthil, S., Zhuxuan, F., Philip, J., Lydia C, K., Sheryl L, W., Olga, I., Christopher B, N., Kenneth B, M., Mansoor, H., Silvio E, I., Darren K, M., Bertram, P., Benjamin M, S., David E, L., Michael E, N., Ali, J., Robert J, M., Mikhail N, K., & Svati H, S. (2023). Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation, 146(11).
Chicago
Senthil, Selvaraj, Fu Zhuxuan, Jones Philip, Kwee Lydia C, Windsor Sheryl L, Ilkayeva Olga, Newgard Christopher B, et al. 2023. “Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.” Circulation 146 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21f8b9870ff2acbe19e09e991ae63ed8&authtype=sso&custid=ns315887.